STERIS plc STE

208.93 0.16 0.08% as of 25 Sep
Market cap
$20.4B
P/E
25.4×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

STERIS plc (STE) Free cash flow

STERIS plc's free cash flow for fiscal 2026 was $982.9M, up 24.9% from $787.2M in fiscal 2025. Over the twelve months to 30 June 2026 it was $936.0M. Over the past ten years it has ranged from $129.1M (fiscal 2016) to $982.9M (fiscal 2026) — the current reading is the highest in ten years. Free cash flow has risen for 4 consecutive fiscal years. STERIS plc ranks 11th of 149 Medical Devices companies by free cash flow.

Free cash flow, annual

Annual

Period Free cash flow Change
FY2026 $982.9M 24.86%
FY2025 $787.2M 26.89%
FY2024 $620.4M 51.48%
FY2023 $409.6M 2.65%
FY2022 $399.0M (11.52%)
FY2021 $450.9M 18.61%
FY2020 $380.2M 6.99%
FY2019 $355.4M 20.76%
FY2018 $294.3M 14.93%
FY2017 $256.0M 98.30%

Quarterly

Period Free cash flow Change
Jun 2026 $279.6M 13.98%
Mar 2026 $245.3M 16.87%
Dec 2025 $209.9M 4.32%
Sep 2025 $201.2M (38.38%)
42 more quarters

Against its own ten years

Low $129.1M High $982.9M
Ten-year median $389.6M
Current reading's percentile 100

Free cash flow against peers

What Free cash flow is

Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.

Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)

The full definition of Free cash flow →

More on STE